hydrogen sulfide has been researched along with Ischemia in 42 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the protective effect of exogenous hydrogen sulfide (H₂S) against myocardial injury after skeletal muscle ischemia/reperfusion (IR) in rats and explore the mechanism." | 7.79 | [Exogenous hydrogen sulfide protects against myocardial injury after skeletal muscle ischemia/reperfusion by inhibiting inflammatory cytokines and oxidative stress in rats]. ( Chen, W; Deng, Z; Li, X; Liu, N; Qi, Y; Xie, X; Yang, J; Zhang, Y, 2013) |
| "Hydrogen sulfide (H2S) is a novel signaling molecule most recently found to be of fundamental importance in cellular function as a regulator of apoptosis, inflammation, and perfusion." | 6.55 | Hydrogen Sulfide: A Potential Novel Therapy for the Treatment of Ischemia. ( DeLeon, ER; Drucker, NA; Ferkowicz, MJ; Jensen, AR; Khaneki, S; Markel, TA; Olson, KR; Yoder, MC, 2017) |
| "Ischemia-reperfusion injury is a critical liver condition during hepatic transplantation, trauma, or shock." | 5.91 | Sodium thiosulfate refuels the hepatic antioxidant pool reducing ischemia-reperfusion-induced liver injury. ( Bauer, M; Clemens, MG; Dahmen, U; Figge, MT; Kan, C; Lupp, A; Medyukhina, A; Nietzsche, S; Pennington, SA; Press, AT; Settmacher, U; Ungelenk, L; Wang, R; Wetzker, R, 2023) |
| "Hydrogen sulfide (H2S) is an endogenous gaseous signaling molecule with significant pathophysiological importance, but its role in retinal neovascular diseases is unknown." | 5.43 | Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy. ( Coletta, C; Gersztenkorn, D; Ha, Y; Liu, H; Motamedi, M; Szabo, C; Tie, H; Zhang, W; Zhou, J; Zhu, S, 2016) |
| "The data demonstrate that H2S bioavailability and nuclear factor-erythroid 2-related factor 2 activation are both attenuated in CLI tissues concomitant with significantly increased oxidative stress." | 5.42 | Hydrogen Sulfide Levels and Nuclear Factor-Erythroid 2-Related Factor 2 (NRF2) Activity Are Attenuated in the Setting of Critical Limb Ischemia (CLI). ( Brewster, LP; Donnarumma, E; Islam, KN; Lefer, DJ; Polhemus, DJ, 2015) |
| "To assess the protective effect of exogenous hydrogen sulfide (H₂S) against myocardial injury after skeletal muscle ischemia/reperfusion (IR) in rats and explore the mechanism." | 3.79 | [Exogenous hydrogen sulfide protects against myocardial injury after skeletal muscle ischemia/reperfusion by inhibiting inflammatory cytokines and oxidative stress in rats]. ( Chen, W; Deng, Z; Li, X; Liu, N; Qi, Y; Xie, X; Yang, J; Zhang, Y, 2013) |
| "Hydrogen sulfide (H(2)S) therapy is recognized as a modulator of vascular function during tissue ischemia with the notion of potential interactions of nitric oxide (NO) metabolism." | 3.78 | Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1α and vascular endothelial growth factor-dependent angiogenesis. ( Bir, SC; Kevil, CG; Kolluru, GK; McCarthy, P; Pardue, S; Pattillo, CB; Shen, X, 2012) |
| "Hydrogen sulfide (H(2)S) is an important signaling molecule that regulates many physiological and pathological processes." | 2.61 | Hydrogen sulfide plays an important protective role by influencing autophagy in diseases. ( Wang, H; Wang, J; Wu, D, 2019) |
| "Hydrogen sulfide (H2S) is a novel signaling molecule most recently found to be of fundamental importance in cellular function as a regulator of apoptosis, inflammation, and perfusion." | 2.55 | Hydrogen Sulfide: A Potential Novel Therapy for the Treatment of Ischemia. ( DeLeon, ER; Drucker, NA; Ferkowicz, MJ; Jensen, AR; Khaneki, S; Markel, TA; Olson, KR; Yoder, MC, 2017) |
| "Hydrogen sulfide (H2 S) has become a molecule of high interest in recent years, and it is now recognized as the third gasotransmitter in addition to nitric oxide and carbon monoxide." | 2.52 | Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. ( Bos, EM; Joles, JA; Leuvenink, HG; van Goor, H; Whiteman, M, 2015) |
| "Ischemia-reperfusion injury is a critical liver condition during hepatic transplantation, trauma, or shock." | 1.91 | Sodium thiosulfate refuels the hepatic antioxidant pool reducing ischemia-reperfusion-induced liver injury. ( Bauer, M; Clemens, MG; Dahmen, U; Figge, MT; Kan, C; Lupp, A; Medyukhina, A; Nietzsche, S; Pennington, SA; Press, AT; Settmacher, U; Ungelenk, L; Wang, R; Wetzker, R, 2023) |
| "Hydrogen sulfide (H2S) has many beneficial biological properties, including the ability to promote vasodilation." | 1.56 | Stem Cell Therapy and Hydrogen Sulfide: Conventional or Nonconventional Mechanisms of Action? ( Drucker, NA; Jensen, AR; Markel, TA; Olson, KR, 2020) |
| "Hydrogen sulfide (H2S) is an endogenous gaseous signaling molecule with significant pathophysiological importance, but its role in retinal neovascular diseases is unknown." | 1.43 | Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy. ( Coletta, C; Gersztenkorn, D; Ha, Y; Liu, H; Motamedi, M; Szabo, C; Tie, H; Zhang, W; Zhou, J; Zhu, S, 2016) |
| "Hydrogen sulfide (H2S) is a vasoactive gasotransmitter that is endogenously produced in the vasculature by the enzyme cystathionine γ-lyase (CSE)." | 1.42 | Cystathionine γ-lyase regulates arteriogenesis through NO-dependent monocyte recruitment. ( Bir, SC; Kevil, CG; Kolluru, GK; Pardue, S; Shen, X; Wang, R; Yuan, S, 2015) |
| "Hydrogen sulfide (H2S) is an important endogenous modulator of diverse physiological and pathophysiological processes." | 1.42 | GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia. ( Liew, OW; Lilyanna, S; Martinez, EC; Moore, PK; Peh, MT; Richards, AM; Wang, P, 2015) |
| "S-memantine was synthesized by chemically combining a slow releasing H(2)S donor 4-(3-thioxo-3H-1,2-dithiol-4-yl)-benzoic acid (ACS48) with a NMDAR antagonist memantine." | 1.38 | A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death. ( Arai, K; Atochin, DN; Ichinose, F; Khatri, A; Kida, K; Kosugi, S; Marutani, E; Nguyen, R; Tokuda, K; Van Leyen, K, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (9.52) | 29.6817 |
| 2010's | 30 (71.43) | 24.3611 |
| 2020's | 8 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Wilkie, SE | 1 |
| Borland, G | 1 |
| Carter, RN | 1 |
| Morton, NM | 1 |
| Selman, C | 1 |
| Omorou, M | 1 |
| Liu, N | 2 |
| Huang, Y | 1 |
| Al-Ward, H | 1 |
| Gao, M | 1 |
| Mu, C | 1 |
| Zhang, L | 1 |
| Hui, X | 1 |
| Zhang, T | 1 |
| Ouyang, H | 1 |
| Liu, S | 2 |
| Xiong, L | 1 |
| Zhong, Z | 1 |
| Wang, Q | 1 |
| Qiu, Z | 1 |
| Ding, Y | 1 |
| Zhou, W | 1 |
| Wang, X | 2 |
| Press, AT | 1 |
| Ungelenk, L | 1 |
| Medyukhina, A | 1 |
| Pennington, SA | 1 |
| Nietzsche, S | 1 |
| Kan, C | 1 |
| Lupp, A | 1 |
| Dahmen, U | 1 |
| Wang, R | 4 |
| Settmacher, U | 1 |
| Wetzker, R | 1 |
| Figge, MT | 1 |
| Clemens, MG | 1 |
| Bauer, M | 1 |
| Uno, Y | 1 |
| Krylatov, A | 1 |
| Maslov, L | 1 |
| Tsibulnikov, SY | 1 |
| Voronkov, N | 1 |
| Boshchenko, A | 1 |
| Downey, J | 1 |
| Mentzer, R | 1 |
| Seker, U | 1 |
| Su, Y | 1 |
| Wang, Y | 1 |
| Liu, M | 1 |
| Chen, H | 1 |
| Jensen, AR | 2 |
| Drucker, NA | 2 |
| Khaneki, S | 1 |
| Ferkowicz, MJ | 1 |
| Yoder, MC | 1 |
| DeLeon, ER | 1 |
| Olson, KR | 2 |
| Markel, TA | 2 |
| Longchamp, A | 1 |
| Mirabella, T | 1 |
| Arduini, A | 1 |
| MacArthur, MR | 1 |
| Das, A | 1 |
| Treviño-Villarreal, JH | 1 |
| Hine, C | 1 |
| Ben-Sahra, I | 1 |
| Knudsen, NH | 1 |
| Brace, LE | 1 |
| Reynolds, J | 1 |
| Mejia, P | 1 |
| Tao, M | 1 |
| Sharma, G | 1 |
| Corpataux, JM | 1 |
| Haefliger, JA | 1 |
| Ahn, KH | 1 |
| Lee, CH | 1 |
| Manning, BD | 1 |
| Sinclair, DA | 1 |
| Chen, CS | 1 |
| Ozaki, CK | 1 |
| Mitchell, JR | 1 |
| Wang, J | 1 |
| Wu, D | 2 |
| Wang, H | 1 |
| Rajendran, S | 1 |
| Shen, X | 3 |
| Glawe, J | 1 |
| Kolluru, GK | 3 |
| Kevil, CG | 4 |
| Chen, W | 1 |
| Zhang, Y | 1 |
| Qi, Y | 1 |
| Yang, J | 1 |
| Deng, Z | 1 |
| Li, X | 1 |
| Xie, X | 2 |
| Wang, WZ | 1 |
| Jones, AW | 1 |
| Wang, M | 2 |
| Durante, W | 1 |
| Korthuis, RJ | 2 |
| Dongó, E | 1 |
| Benkő, Z | 1 |
| Csizmazia, Á | 1 |
| Marosi, G | 1 |
| Grottke, A | 1 |
| Jücker, M | 1 |
| Schumacher, U | 1 |
| Kiss, L | 1 |
| Bos, EM | 1 |
| van Goor, H | 1 |
| Joles, JA | 1 |
| Whiteman, M | 1 |
| Leuvenink, HG | 1 |
| Jin, Z | 1 |
| Chan, H | 1 |
| Ning, J | 1 |
| Lu, K | 1 |
| Ma, D | 1 |
| Islam, KN | 1 |
| Polhemus, DJ | 1 |
| Donnarumma, E | 1 |
| Brewster, LP | 1 |
| Lefer, DJ | 1 |
| Balaban, CL | 1 |
| Rodríguez, JV | 1 |
| Tiribelli, C | 1 |
| Guibert, EE | 1 |
| Tao, BB | 1 |
| Cai, WJ | 2 |
| Zhu, YC | 2 |
| Bir, SC | 2 |
| Yuan, S | 2 |
| Pardue, S | 2 |
| Aykan, A | 1 |
| Ozturk, S | 1 |
| Sahin, I | 1 |
| Avcu, F | 1 |
| Sagkan, RI | 1 |
| Isik, S | 1 |
| Lilyanna, S | 1 |
| Peh, MT | 1 |
| Liew, OW | 1 |
| Wang, P | 1 |
| Moore, PK | 1 |
| Richards, AM | 1 |
| Martinez, EC | 1 |
| Hu, Q | 1 |
| Ma, F | 1 |
| Yang, S | 1 |
| Tan, B | 1 |
| Xin, H | 1 |
| Gu, X | 1 |
| Chen, X | 1 |
| Chen, S | 1 |
| Mao, Y | 1 |
| Zhu, YZ | 1 |
| Gersztenkorn, D | 1 |
| Coletta, C | 1 |
| Zhu, S | 1 |
| Ha, Y | 1 |
| Liu, H | 2 |
| Tie, H | 1 |
| Zhou, J | 1 |
| Szabo, C | 1 |
| Zhang, W | 1 |
| Motamedi, M | 1 |
| Zhang, Q | 1 |
| Li, T | 1 |
| Yuan, L | 1 |
| Wang, F | 1 |
| Wang, S | 1 |
| Hao, A | 1 |
| Liu, D | 1 |
| Wang, Z | 1 |
| Sen, N | 1 |
| Schmidt, C | 1 |
| Wang, MJ | 1 |
| Li, N | 1 |
| Ding, YJ | 1 |
| Chen, Y | 2 |
| Zuidema, MY | 1 |
| Yang, Y | 1 |
| Kalogeris, T | 1 |
| Liu, Y | 1 |
| Meininger, CJ | 1 |
| Hill, MA | 1 |
| Davis, MJ | 1 |
| Liu, Z | 1 |
| Minamishima, S | 1 |
| Ichinose, F | 2 |
| Liu, YH | 1 |
| Lu, M | 1 |
| Bian, JS | 1 |
| Marutani, E | 1 |
| Kosugi, S | 1 |
| Tokuda, K | 1 |
| Khatri, A | 1 |
| Nguyen, R | 1 |
| Atochin, DN | 1 |
| Kida, K | 1 |
| Van Leyen, K | 1 |
| Arai, K | 1 |
| Widgerow, AD | 1 |
| McCarthy, P | 1 |
| Pattillo, CB | 1 |
| Roth, MB | 1 |
| Nystul, T | 1 |
| Tisherman, SA | 1 |
| Drabek, T | 1 |
| Li, J | 1 |
| Zhang, G | 1 |
| Cai, S | 1 |
| Redington, AN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short-Term Endogenous Hydrogen Sulfide Upregulation For Vein Graft Disease[NCT05457881] | 226 participants (Anticipated) | Interventional | 2024-03-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for hydrogen sulfide and Ischemia
| Article | Year |
|---|---|
Hydrogen sulfide in ageing, longevity and disease.
Topics: Aging; Animals; Extremities; Gasotransmitters; Humans; Hydrogen Sulfide; Ischemia; Longevity; Metall | 2021 |
Cystathionine beta-Synthase in hypoxia and ischemia/reperfusion: A current overview.
Topics: Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Hypoxia; Ischemia; | 2022 |
The Role of Reactive Oxygen Species, Kinases, Hydrogen Sulfide, and Nitric Oxide in the Regulation of Autophagy and Their Impact on Ischemia and Reperfusion Injury in the Heart.
Topics: Autophagy; Humans; Hydrogen Sulfide; Ischemia; Myocytes, Cardiac; Nitric Oxide; Reactive Oxygen Spec | 2021 |
Hydrogen Sulfide: A Potential Novel Therapy for the Treatment of Ischemia.
Topics: Apoptosis; Cell Death; Humans; Hydrogen Sulfide; Ischemia; Sepsis; Signal Transduction | 2017 |
Hydrogen sulfide plays an important protective role by influencing autophagy in diseases.
Topics: Animals; Autophagy; Cell Proliferation; Cytoprotection; Gasotransmitters; Humans; Hydrogen Sulfide; | 2019 |
Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.
Topics: Cardiovascular Diseases; Humans; Hydrogen Sulfide; Intercellular Signaling Peptides and Proteins; Is | 2019 |
Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.
Topics: Animals; Gasotransmitters; Humans; Hydrogen Sulfide; Hypoxia; Ischemia | 2015 |
The role of hydrogen sulfide in pathologies of the vital organs and its clinical application.
Topics: Animals; Chronic Disease; Humans; Hydrogen Sulfide; Ischemia; Pharmaceutical Preparations | 2015 |
H2S Is a Promoter of Angiogenesis: Identification of H2S "Receptors" and Its Molecular Switches in Vascular Endothelial Cells.
Topics: Animals; Endothelial Cells; Humans; Hydrogen Sulfide; Ischemia; Neovascularization, Physiologic; Rec | 2015 |
Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling.
Topics: Animals; Humans; Hydrogen Sulfide; Ischemia; Neovascularization, Pathologic; Nitric Oxide; Vascular | 2016 |
Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration.
Topics: Animals; Brain Injuries, Traumatic; Cell Cycle; Cell Differentiation; Cell Proliferation; Fibrosis; | 2017 |
[Emerging role of hydrogen sulfide in biology].
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Brain Ischemia; Cardiopulmonary Resuscitation; Heart A | 2010 |
Hydrogen sulfide and renal ischemia.
Topics: Animals; Homocysteine; Humans; Hydrogen Sulfide; Ischemia; Kidney; Kidney Diseases; Signal Transduct | 2011 |
Ischemia-reperfusion injury: influencing the microcirculatory and cellular environment.
Topics: Cardiovascular Agents; Cell Adhesion Molecules; Endothelium-Dependent Relaxing Factors; Free Radical | 2014 |
28 other studies available for hydrogen sulfide and Ischemia
| Article | Year |
|---|---|
pH/Thermosensitive dual-responsive hydrogel based sequential delivery for site-specific acute limb ischemia treatment.
Topics: Alginates; Allyl Compounds; Cellulose; Delayed-Action Preparations; Humans; Hydrogels; Hydrogen Sulf | 2022 |
Sodium thiosulfate refuels the hepatic antioxidant pool reducing ischemia-reperfusion-induced liver injury.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury, Chronic; Glutathione; Hydrogen Sulfid | 2023 |
Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease.
Topics: Diet; Disaccharides; Fermentation; Humans; Hydrogen Sulfide; Hydrogen-Ion Concentration; Inflammator | 2019 |
Letter to the Editor: "Protective effect of hydrogen sulfide on experimental testicular ischemia reperfusion in rats" Gains and troubles of an experimental study.
Topics: Animals; Humans; Hydrogen Sulfide; Ischemia; Male; Rats; Reperfusion; Spermatic Cord Torsion; Testis | 2021 |
Hydrogen sulfide attenuates renal I/R‑induced activation of the inflammatory response and apoptosis via regulating Nrf2‑mediated NLRP3 signaling pathway inhibition.
Topics: Acute Kidney Injury; Animals; Apoptosis; Caspase 1; Gene Expression Regulation; Heme Oxygenase-1; Hy | 2021 |
Amino Acid Restriction Triggers Angiogenesis via GCN2/ATF4 Regulation of VEGF and H
Topics: Activating Transcription Factor 4; Amino Acids, Sulfur; Animals; Cystathionine gamma-Lyase; Disease | 2018 |
Stem Cell Therapy and Hydrogen Sulfide: Conventional or Nonconventional Mechanisms of Action?
Topics: Animals; Gene Knockdown Techniques; Humans; Hydrogen Sulfide; Intestines; Ischemia; Male; Mesenchyma | 2020 |
[Exogenous hydrogen sulfide protects against myocardial injury after skeletal muscle ischemia/reperfusion by inhibiting inflammatory cytokines and oxidative stress in rats].
Topics: Animals; Creatine Kinase, MB Form; Disease Models, Animal; Hydrogen Sulfide; Ischemia; Male; Malondi | 2013 |
Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
Topics: Animals; Benzoates; Biphenyl Compounds; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal | 2013 |
H2S preconditioning of human adipose tissue-derived stem cells increases their efficacy in an in vitro model of cell therapy for simulated ischemia.
Topics: Adipose Tissue; Adult; Alkynes; Animals; Antioxidants; Cell Line; Cell Proliferation; Cell Survival; | 2014 |
Hydrogen Sulfide Levels and Nuclear Factor-Erythroid 2-Related Factor 2 (NRF2) Activity Are Attenuated in the Setting of Critical Limb Ischemia (CLI).
Topics: Aged; Amputation, Surgical; Biomarkers; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Fema | 2015 |
The effect of a hydrogen sulfide releasing molecule (Na2S) on the cold storage of livers from cardiac dead donor rats. A study in an ex vivo model.
Topics: Animals; Cryopreservation; Cytoprotection; Glucose; Heme Oxygenase-1; Hydrogen Sulfide; Ischemia; Li | 2015 |
Cystathionine γ-lyase regulates arteriogenesis through NO-dependent monocyte recruitment.
Topics: Animals; Cystathionine gamma-Lyase; Cytokines; Disease Models, Animal; Hydrogen Sulfide; Ischemia; M | 2015 |
The Effects of Hydrogen Sulfide on Adipocyte Viability in Human Adipocyte and Adipocyte-Derived Mesenchymal Stem Cell Cultures Under Ischemic Conditions.
Topics: Adipocytes; Apoptosis; Cell Proliferation; Cell Survival; Female; Humans; Hydrogen Sulfide; Ischemia | 2015 |
GYY4137 attenuates remodeling, preserves cardiac function and modulates the natriuretic peptide response to ischemia.
Topics: Animals; Atrial Natriuretic Factor; Cardiotonic Agents; Humans; Hydrogen Sulfide; Ischemia; Morpholi | 2015 |
Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
Topics: Angiogenesis Inducing Agents; Animals; Cyclic GMP; Cystathionine gamma-Lyase; Delayed-Action Prepara | 2016 |
Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy.
Topics: Animals; Blotting, Western; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, | 2016 |
Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain Diseases; Brain-Derived Neurotrophic Factor; C | 2016 |
Mark Roth.
Topics: Animals; Biotechnology; Hibernation; History, 20th Century; History, 21st Century; Humans; Hydrogen | 2009 |
The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia.
Topics: Animals; Cell Communication; Endothelial Cells; Extremities; Hemodynamics; Hydrogen Sulfide; Ischemi | 2010 |
Hydrogen sulfide: the third gasotransmitter in biology and medicine.
Topics: Animals; Antioxidants; Humans; Hydrogen Sulfide; Hypoxia; Inflammation; Ischemia; Neurodegenerative | 2010 |
Antecedent hydrogen sulfide elicits an anti-inflammatory phenotype in postischemic murine small intestine: role of BK channels.
Topics: Animals; Apamin; Cells, Cultured; Electrophysiological Phenomena; Endothelium, Vascular; Humans; Hyd | 2010 |
Hydrogen sulphide attenuates renal and cardiac injury after total hepatic ischemia and reperfusion.
Topics: Animals; Cell Adhesion Molecules; Enzyme-Linked Immunosorbent Assay; Hepatic Artery; Hydrogen Sulfid | 2010 |
A novel hydrogen sulfide-releasing N-methyl-D-aspartate receptor antagonist prevents ischemic neuronal death.
Topics: Animals; Brain Injuries; Brain Ischemia; Cell Death; Cell Line, Tumor; Cells, Cultured; Drug Design; | 2012 |
Hydrogen sulfide stimulates ischemic vascular remodeling through nitric oxide synthase and nitrite reduction activity regulating hypoxia-inducible factor-1α and vascular endothelial growth factor-dependent angiogenesis.
Topics: Animals; Enzyme-Linked Immunosorbent Assay; Hydrogen Sulfide; Hypoxia-Inducible Factor 1, alpha Subu | 2012 |
Buying time in suspended animation.
Topics: Animals; Caenorhabditis elegans; Cold Temperature; Energy Metabolism; Humans; Hydrogen Sulfide; Hypo | 2005 |
Hydrogen sulfide: metabolic mediator or toxic gas?
Topics: Administration, Inhalation; Anesthesia; Animals; Hydrogen Sulfide; Hypothermia, Induced; Ischemia; M | 2008 |
Effect of inhaled hydrogen sulfide on metabolic responses in anesthetized, paralyzed, and mechanically ventilated piglets.
Topics: Administration, Inhalation; Anesthesia; Animals; Carbon Dioxide; Cardiac Output; Heart Rate; Hydroge | 2008 |